FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
From - National Intelligence Report
While Big Data can mean new opportunities for increasing efficiencies and revenues for the laboratory industry, the Centers for Medicare & Medicaid Services (CMS) claims Big Data has yielded big savings for…
From - National Intelligence Report
Roche announced last week that the U.S. Food and Drug Administration (FDA) approved the cobas® EGFR Mutation Test v2 "for use with…
From - National Intelligence Report
The U.S. Department of Health and Human Services (HHS), in collaboration with AARP, is challenging health care organizations to design a…